- For-profit research institute targeting regenerative medicine and focusing on development of stem-cell research derived products, techniques, apparatus, and related technological advancements, many of which have been pioneered by founding members
- Treatments and products will be focused on enhancing the quality of life of patients stricken with chronic diseases entering the end stages of their ailments
- Structured to follow the pharmaceutical business model
- – Enormously successful, profit-driven model
- – Not dependent on the constant need for grant money, publishing, and circumvents current bureaucratic quagmire
- – Withstanding the test of time through a variety of difficult economic and regulatory environments
- Focus will be on establishing new standards of care utilizing the break-through products and technologies pioneered by the company
- Targeting to pursue 8 different product lines to diversify business risks and maximize profit opportunities